This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Use of entacapone
PDMED_ENTACAPONE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
306 |
4. Check minimum number of events
Min. number of events
3
|
306 |
5. Include endpointsNone |
306 |
6. Filter based on genotype QC (FinnGen only) |
306 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Use of entacapone
based on the number of shared cases.
Similar with more cases:
- Use of levodopa decarboxylase inhibitor
- Parkinson's disease
- Parkinson's disease, excluding more controls
- Parkinson's disease, including avohilmo
- Extrapyramidal and movement disorders
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 306 | 112 | 194 |
| Unadjusted period prevalence (%) | 0.07 | 0.04 | 0.09 |
| Median age at first event (years) | 69.00 | 67.08 | 70.11 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 271
- Matched controls
- 2707
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
+∞
323.0
271
61
N04BX02
ATC
entacapone; oral
+∞
323.0
271
*
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
6756.1
323.0
269
49
G20
ICD-10 Finland
Parkinson disease
4275.2
323.0
268
49
N04BD01
ATC
selegiline; oral
374.5
219.1
197
19
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
585.0
212.7
186
10
N04BC05
ATC
pramipexole; oral
47.7
141.3
182
111
N04BC04
ATC
ropinirole; oral
113.3
91.6
96
13
N04BD02
ATC
rasagiline; oral
219.4
90.4
89
6
N87
ICPC
Parkinsonism
73.5
83.4
93
19
193
Kela drug reimbursment
Rasagiline
188.0
80.0
80
6
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
217.7
78.8
78
5
N04BB01
ATC
amantadine; oral
61.3
59.9
69
15
N04BC02
ATC
pergolide; oral
+∞
54.0
50
*
N05AH04
ATC
quetiapine; oral
9.6
50.6
120
207
G02CB01
ATC
bromocriptine; systemic
156.3
49.7
51
*
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
449.2
40.2
39
*
N04BC06
ATC
cabergoline; oral (dopamine agonists)
+∞
38.5
36
*
N04BC09
ATC
rotigotine; transdermal
142.2
35.7
37
*
N06DA03
ATC
rivastigmine; oral, transdermal
11.7
35.0
68
75
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
378.2
33.7
33
*
N03AE01
ATC
clonazepam; systemic
12.6
33.4
62
62
N04AA02
ATC
biperiden; systemic
24.7
31.2
44
21
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
95.6
24.1
26
*
3320A
ICD-9 Finland
Parkinson's disease, Paralysis agitans
91.5
23.1
25
*
A06AD11
ATC
lactulose; oral
3.6
18.1
99
370
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
5.2
17.6
58
134
H02AA02
ATC
fludrocortisone; oral
23.8
17.2
24
11
N04BC01
ATC
bromocriptine; oral
+∞
16.8
16
*
N04BX01
ATC
tolcapone; oral
+∞
16.8
16
*
F02.39
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
180.7
16.7
17
*
XA800
NOMESCO Finland
Neuropsychological investigation
10.0
16.5
33
37
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
50.8
16.2
19
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
5.5
15.0
46
97
JDB10
NOMESCO Finland
Percutaneous gastrostomy
17.0
14.2
22
14
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
42.4
13.3
16
*
R25.1
ICD-10 Finland
Tremor, unspecified
7.8
11.9
27
38
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.2
11.6
67
249
Z2445
NOMESCO Finland
Psychologist
8.7
11.4
24
30
N05BA04
ATC
oxazepam; oral
2.7
11.1
90
419
R13
ICD-10 Finland
Dysphagia
4.9
10.9
36
82
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.5
10.8
118
647
R47.1
ICD-10 Finland
Dysarthria and anarthria
16.9
10.5
16
10
N05AH02
ATC
clozapine; systemic
41.7
10.0
12
*
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
14.1
9.8
16
12
I95.1
ICD-10 Finland
Orthostatic hypotension
4.8
9.2
30
68
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.8
8.4
60
253
N06AB10
ATC
escitalopram; oral
2.9
8.3
54
215
N06AB04
ATC
citalopram; systemic
2.4
7.7
75
373
AA1AA
NOMESCO Finland
Head X-ray examination
25.8
7.6
10
*
N06AX11
ATC
mirtazapine; oral
2.2
7.6
91
502
R53
ICD-10 Finland
Malaise and fatigue
2.3
7.6
78
400
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
82.3
7.5
8
*
XKD06
NOMESCO Finland
Physiologic investigation of micturition
5.5
7.4
21
41
N86
ICPC
Multiple sclerosis
+∞
7.3
7
*
S01.0
ICD-10 Finland
Open wound of scalp
3.2
7.2
38
132
S72.0
ICD-10 Finland
Fracture of neck of femur
3.7
7.2
31
92
G04BD12
ATC
mirabegron; oral
2.9
7.2
44
167
N06AX03
ATC
mianserin; oral
4.4
7.0
24
58
C07AA05
ATC
propranolol; systemic
2.6
6.8
51
220
R4130
NOMESCO Finland
Speech therapy
6.7
6.7
16
25
N05CD07
ATC
temazepam; oral
2.3
6.6
63
310
A98
ICPC
Health maint/preventive medicine
0.5
6.6
140
1831
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
4.1
6.6
24
62
R1250
NOMESCO Finland
Evaluation of functional capability
7.7
6.5
14
19
N04AA01
ATC
trihexyphenidyl; oral
71.5
6.5
7
*
N19
ICPC
Speech disorder
14.8
6.4
10
7
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
6.4
106
662
N30.0
ICD-10 Finland
Acute cystitis
2.6
6.3
47
203
N04BC07
ATC
apomorphine; parenteral
+∞
6.3
6
*
AAW01
NOMESCO Finland
Implantation of intracranial stimulation device
+∞
6.3
6
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.4
6.3
56
267
N30.9
ICD-10 Finland
Cystitis, unspecified
3.6
6.1
26
77
I10
ICD-10 Finland
Essential (primary) hypertension
0.5
6.1
102
1448
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.2
6.1
31
106
K59.09
ICD-10 Finland
Constipation, unspecified
3.5
6.0
27
84
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
111
1829
0.38
14.45
3.2
4.3
mmol/l
1.2
1.3
0.08
97
1610
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
118
1883
0.39
14.01
3.3
4.8
mmol/l
1.4
1.4
1.10
102
1669
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
120
1896
0.40
13.80
3.3
4.9
mmol/l
4.2
4.4
1.51
106
1702
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
134
1957
0.44
11.20
3.4
5.5
mmol/l
2.4
2.5
0.80
114
1729
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
130
1906
0.45
10.67
5.2
6.7
mmol/mol
40.0
41.5
1.00
120
1724
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
140
1946
0.48
8.89
3.6
5.1
mmol/l
5.8
6.2
2.64
122
1709
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
160
2102
0.50
8.09
7.4
11.0
u/l
14.2
23.5
15.59
139
1994
(3020682) Albumin/Creatinine [Ratio] in Urine
30
703
0.36
6.82
3.3
3.9
mg/mmol
4.4
10.4
1.65
23
442
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
73
1177
0.50
6.20
2.3
3.1
u/l
58.6
54.5
0.08
67
1069
(3010813) Leukocytes [#/volume] in Blood
176
2176
0.55
5.97
29.2
25.6
e9/l
6.5
6.9
1.84
169
2087
(3026361) Erythrocytes [#/volume] in Blood
176
2175
0.55
5.94
29.1
25.6
e12/l
4.3
4.4
1.13
168
2083
(3007461) Platelets [#/volume] in Blood
176
2174
0.55
5.91
29.4
25.6
e9/l
245.6
236.4
1.27
171
2094
(3013512) EKG study
36
733
0.42
5.74
3.8
4.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
144
1873
0.56
5.70
20.5
16.9
ml/min/173m2
86.2
71.5
15.17
116
1540
(3012516) Albumin [Mass/volume] in Urine
30
657
0.40
5.70
2.2
3.1
mg/l
22.0
248.0
1.03
22
430
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
139
1812
0.57
5.37
4.1
4.6
mu/l
1.9
2.0
0.59
127
1574
(3009508) Creatinine [Moles/volume] in Urine
32
659
0.43
5.17
2.2
3.1
mmol/l
6.7
7.0
0.16
27
519
(3013707) Erythrocyte sedimentation rate by Westergren method
113
1534
0.58
4.86
2.9
4.2
mm/h
12.6
15.2
1.18
106
1374
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
61
953
0.55
4.22
4.7
5.3
ug/l
5.7
3.9
0.30
55
825
(40761511) CBC panel - Blood by Automated count
171
2059
0.62
4.12
18.5
16.9
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
17
61
2.89
3.75
3.2
4.5
mg/l
26.8
33.4
0.39
12
41
(3019225) pH of Specimen
7
227
0.29
3.64
4.3
3.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
170
2022
0.64
3.53
21.4
17.7
mg/l
30.3
26.7
0.61
148
1673
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
132
1653
0.65
3.46
4.6
7.4
u/l
84.3
80.3
0.41
119
1533
(3026493) Urate [Moles/volume] in Serum or Plasma
32
574
0.51
3.37
3.3
2.8
umol/l
16706.1
9831.0
0.25
26
464
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
58
867
0.59
3.23
3.0
3.2
ng/l
1676.9
2009.0
0.22
49
735
(3022217) INR in Platelet poor plasma by Coagulation assay
17
371
0.43
3.07
29.9
28.7
—
1.4
—
0
50
(3022145) Colonoscopy Study observation
9
237
0.36
2.95
1.2
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
115
1452
0.67
2.92
3.3
3.8
pmol/l
14.5
15.1
1.57
100
1252
(3000850) Epithelial cells [#/volume] in Urine
75
520
1.59
2.87
2.9
2.7
e6/l
6.1
4.4
0.44
67
456
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
89
1180
0.65
2.86
3.7
6.0
umol/l
9.9
11.9
1.98
83
1108
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
0
73
0.00
2.82
0.0
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
101
763
1.48
2.59
4.5
3.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
11
5.54
2.55
1.3
1.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
29
159
1.91
2.54
4.8
2.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
60
841
0.64
2.43
2.8
2.7
ug/l
150.7
149.7
0.01
52
748
(3033658) Prothrombin time (PT) actual/Normal
75
540
1.52
2.41
4.1
3.7
%
86.4
83.9
0.46
75
529
(1761868) Lipid panel - Serum or Plasma
36
568
0.58
2.40
3.3
3.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
96
728
1.46
2.39
4.3
3.5
e6/l
46.0
151.6
0.64
77
575
(36304419) Bacteria [Presence] in Urine
83
614
1.48
2.33
4.1
3.3
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
70
940
0.67
2.28
8.2
5.3
%
64.4
59.5
3.66
61
865
(4035726)
8
196
0.39
2.26
1.1
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
56
383
1.57
2.26
3.6
2.9
e6/l
1.0
1.0
0.05
29
221
(40768804) Tissue Pathology biopsy report
57
794
0.65
2.21
1.6
2.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
104
812
1.43
2.19
4.5
4.0
e6/l
217.9
96.7
0.88
78
609
(3009542) Hematocrit [Volume Fraction] of Blood
144
1694
0.72
2.19
23.6
19.0
%
37.3
38.3
0.43
90
1033
(3019198) Lymphocytes [#/volume] in Blood
77
1008
0.68
2.17
6.4
5.2
e9/l
1.5
1.7
2.83
65
885
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
54
370
1.56
2.16
3.7
3.1
e6/l
2.4
1.5
0.36
27
213
(3013650) Neutrophils [#/volume] in Blood by Automated count
93
1175
0.70
2.15
8.8
8.7
e9/l
4.6
4.3
0.41
71
1018
(3002030) Lymphocytes/100 leukocytes in Blood
73
959
0.69
2.08
7.2
5.5
%
22.3
25.0
1.71
62
874
(3013115) Eosinophils [#/volume] in Blood
80
1033
0.69
2.08
6.1
5.3
e9/l
0.2
0.2
1.13
68
897
(3006315) Basophils [#/volume] in Blood
77
995
0.70
1.99
6.2
5.1
e9/l
0.0
0.0
0.59
57
848
(3006504) Eosinophils/100 leukocytes in Blood
72
941
0.69
1.98
7.1
5.2
%
2.7
2.7
0.15
62
865
(3044889) 12 lead EKG panel
124
1475
0.73
1.91
3.6
4.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
14
273
0.49
1.89
2.9
4.4
ug/l
2.9
52.4
—
8
238
(3019069) Monocytes/100 leukocytes in Blood
73
945
0.70
1.89
7.0
5.5
%
7.8
8.9
3.42
62
870
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
56
761
0.68
1.89
4.4
4.6
%
14.1
21.8
4.81
22
399
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
78
997
0.71
1.87
4.5
4.5
ng/l
37.3
47.1
0.27
61
776
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
54
0.00
1.87
0.0
1.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
77
986
0.71
1.87
6.2
5.1
e9/l
0.5
0.6
4.30
57
835
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
37
541
0.64
1.78
2.8
3.1
ug/l
0.6
0.9
1.92
26
377
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
42
288
1.53
1.69
2.1
1.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
103
834
1.35
1.69
4.0
3.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
72
918
0.72
1.67
7.0
5.3
%
0.6
0.6
0.11
62
843
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
13
248
0.50
1.66
1.8
2.6
ug/l
3.3
7.0
2.18
13
214
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
9
184
0.47
1.56
2.3
3.3
kpa
4.9
5.2
—
9
167
(3014051) Protein [Presence] in Urine by Test strip
10
44
2.32
1.55
3.3
2.5
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
0
43
0.00
1.53
0.0
1.1
—
30.1
—
0
37
(40760892) CBC W Ordered Manual Differential panel - Blood
26
396
0.62
1.50
3.8
5.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
82
653
1.35
1.48
4.4
3.3
e6/l
0.3
0.5
1.21
63
501
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
9
180
0.48
1.44
1.1
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
41
290
1.48
1.44
2.2
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
120
0.41
1.40
2.2
2.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
10
194
0.50
1.36
6.3
8.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
40
0.00
1.33
0.0
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
24
2.53
1.31
1.0
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
50
652
0.72
1.31
2.8
2.1
mg/l
3.4
3.3
0.05
40
540
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
8
157
0.50
1.29
1.3
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
6
130
0.45
1.18
2.3
3.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
41
543
0.72
1.18
2.0
1.9
pmol/l
347.3
13164410.6
0.50
34
433
(3045142) Bone marrow Pathology biopsy report
0
33
0.00
1.17
0.0
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
34
0.00
1.16
0.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
13
73
1.82
1.12
2.8
2.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
58
458
1.33
1.11
4.4
4.6
kg/l
1.0
1.0
—
6
70
(3024561) Albumin [Mass/volume] in Serum or Plasma
89
1037
0.80
0.99
4.6
4.1
g/l
34.6
34.5
0.02
84
950
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
29
0.00
0.98
0.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
29
0.00
0.98
0.0
4.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
29
0.00
0.98
0.0
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
30
0.00
0.98
0.0
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
30
0.00
0.98
0.0
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
30
0.00
0.98
0.0
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
30
0.00
0.98
0.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
30
0.00
0.98
0.0
4.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
30
0.00
0.98
0.0
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
34
449
0.73
0.97
1.5
1.7
mg/l
1.2
1.5
0.26
28
361
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
31
0.00
0.97
0.0
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
31
0.00
0.97
0.0
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
36
273
1.36
0.91
5.4
3.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
72
604
1.25
0.88
1.9
1.7
nmol/l
21.0
20.7
0.05
62
493
(3026782) Osmolality of Urine
61
503
1.27
0.86
3.6
3.1
mosm/kgh2o
643.7
557.6
2.00
52
427
(3005719) IgG [Mass/volume] in Serum or Plasma
8
140
0.56
0.85
9.5
2.5
g/l
7.1
9.9
—
8
124
(3017143) Hepatitis C virus Ab [Presence] in Serum
9
148
0.60
0.81
1.1
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
104
1170
0.83
0.79
5.2
6.1
mmol/l
1.2
1.2
0.14
94
954
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
25
0.00
0.79
0.0
2.9
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
25
0.00
0.79
0.0
2.2
—
449.2
—
0
13
(3026389) Candida sp identified in Specimen by Organism specific culture
0
27
0.00
0.78
0.0
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
21
288
0.71
0.77
1.2
1.2
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
28
0.00
0.76
0.0
1.4
—
253.7
—
0
28
(3004588) Protein electrophoresis panel - Serum or Plasma
12
184
0.64
0.76
2.3
2.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
67
784
0.81
0.76
3.3
3.0
mmol/l
2.3
2.3
0.95
61
672
(3029937) Albumin [Presence] in Urine by Test strip
69
587
1.23
0.75
5.0
4.5
estimate
0.0
0.0
0.00
24
196
(3013826) Glucose [Moles/volume] in Serum or Plasma
122
1344
0.85
0.72
5.1
4.7
mmol/l
6.3
6.9
3.86
117
1266
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
10
156
0.63
0.69
1.1
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
9
59
1.54
0.69
2.3
4.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
26
334
0.76
0.64
1.4
1.5
g/l
1.9
2.7
—
9
186
(42870588) Differential panel, method unspecified - Blood
60
695
0.83
0.62
5.1
5.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
1.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
11
72
1.55
0.60
2.2
3.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
67
582
1.19
0.59
6.5
3.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
22
0.00
0.59
0.0
1.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
22
0.00
0.59
0.0
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
22
0.00
0.59
0.0
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
23
0.00
0.58
0.0
1.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
112
1018
1.16
0.58
5.1
4.2
estimate
0.0
0.0
0.00
23
208
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
20
150
1.36
0.57
2.0
1.7
—
—
—
0
0
(3012501) Base excess in Blood by calculation
9
63
1.44
0.53
3.8
4.4
mmol/l
2.3
2.9
—
9
36
(3021601) Nitrite [Presence] in Urine by Test strip
111
1020
1.14
0.48
7.7
5.7
estimate
0.0
0.0
0.00
20
202
(3011397) Hemoglobin [Presence] in Urine by Test strip
52
452
1.18
0.47
3.3
4.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
90
818
1.14
0.46
6.1
4.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
112
1033
1.13
0.46
5.6
4.2
estimate
0.0
0.0
0.00
24
197
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
22
274
0.79
0.46
6.5
8.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
156
1469
1.13
0.45
7.0
5.0
e6/l
9930.9
3600.7
0.48
14
39
(3007853) Bacteria identified in Skin by Aerobe culture
32
267
1.22
0.44
1.6
1.7
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
31
369
0.82
0.43
2.6
2.8
mmol/l
0.8
0.8
0.42
31
337
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
99
1071
0.89
0.41
4.6
5.6
mmol/l
1.2
1.2
0.38
93
961
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
15
0.00
0.41
0.0
1.3
—
1.5
—
0
9
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
17
0.00
0.41
0.0
4.3
—
—
—
0
0
(4281824)
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
35
298
1.20
0.40
5.1
6.4
mmol/l
2.3
1.4
0.55
26
242
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
18
0.00
0.40
0.0
1.1
—
36.5
—
0
10
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
18
0.00
0.40
0.0
1.3
—
7.3
—
0
12
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.0
—
270.2
—
0
10
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.0
—
485.0
—
0
11
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3016750) Collection duration of Urine
0
19
0.00
0.39
0.0
2.0
—
478.6
—
0
11
(4146454)
0
19
0.00
0.39
0.0
2.9
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
16
202
0.78
0.38
2.8
2.9
kpa
3.9
4.2
0.44
16
192
(3049717) Cytology report of Urine Cyto stain
8
113
0.70
0.38
2.9
3.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
39
338
1.18
0.38
1.9
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
57
633
0.88
0.36
2.7
2.8
u/l
26.6
33.1
1.09
57
602
(3004716) Salmonella sp identified in Stool by Organism specific culture
5
78
0.64
0.36
1.2
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
16
126
1.28
0.36
6.1
4.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
20
243
0.81
0.35
1.4
1.3
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
19
232
0.81
0.35
2.6
3.7
kpa
6.0
5.8
0.31
19
223
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
47
417
1.15
0.34
2.3
1.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
6
87
0.68
0.33
10.8
5.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
47
1.28
0.32
1.2
1.4
—
—
—
0
0
(3020891) Body temperature
7
98
0.71
0.31
3.4
4.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
53
1.33
0.31
1.0
1.3
—
—
—
0
0
(3012544) pH of Venous blood
20
239
0.83
0.31
2.6
3.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
54
1.30
0.30
1.6
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
54
1.30
0.30
1.6
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
49
541
0.89
0.29
1.9
2.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
15
122
1.24
0.27
8.7
8.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
83
886
0.91
0.27
11.5
10.7
e9/l
0.0
0.0
0.65
56
715
(3028626) Oxygen [Partial pressure] in Capillary blood
5
75
0.66
0.26
2.4
2.1
kpa
8.5
7.6
—
5
66
(3010421) pH of Blood
9
72
1.26
0.26
3.8
4.5
ph
7.4
7.4
—
9
62
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
82
0.73
0.24
1.2
1.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
85
0.70
0.24
3.5
2.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
12
147
0.81
0.24
1.4
2.1
nmol/l
11.8
12.7
0.11
12
130
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
7
95
0.73
0.22
2.0
2.9
pmol/l
4.5
4.3
—
7
81
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
80
847
0.92
0.21
2.1
2.2
nmol/l
68.0
78.6
3.03
69
720
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
25.5
—
0
11
(3043410) Blood group antigens tested for on Red Blood Cells
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
10
0.00
0.21
0.0
1.2
—
8.5
—
0
10
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
14
0.00
0.20
0.0
2.3
—
382.6
—
0
7
(3051593) INR in Capillary blood by Coagulation assay
0
14
0.00
0.20
0.0
13.0
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
0
14
0.00
0.20
0.0
1.4
—
68.9
—
0
8
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
76
718
1.08
0.19
2.6
4.0
ph
7.4
7.4
—
9
141
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
44
476
0.91
0.19
2.3
3.1
mmol/l
2.5
2.5
0.10
37
413
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
14
164
0.85
0.19
4.4
2.8
ml/min/173m2
80.7
56.5
—
6
65
(3023368) Bacteria identified in Blood by Culture
77
732
1.07
0.17
4.2
4.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
67
0.74
0.17
1.2
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
67
0.74
0.17
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
67
0.74
0.17
1.2
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
10
120
0.83
0.17
1.1
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
6
80
0.75
0.15
1.8
2.0
u/ml
1.0
0.4
—
6
38
(3002256) Pathology report gross observation
23
253
0.90
0.14
1.3
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
48
509
0.93
0.14
5.9
6.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
95
985
0.95
0.14
3.9
4.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
16
179
0.89
0.12
1.4
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
106
1033
1.04
0.09
7.8
11.4
inr
1.3
1.4
0.55
26
293
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
20
217
0.92
0.09
2.4
3.1
ng/l
124.6
236.4
1.76
15
190
(3015171) Extractable nuclear Ab [Units/volume] in Serum
5
47
1.06
0.09
1.2
1.2
—
3.0
—
0
6
(46235355) HIV 1 and 2 tests - Meaningful Use set
16
175
0.91
0.08
1.1
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
6
58
1.04
0.08
1.0
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
61
0.82
0.08
2.4
2.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
65
1.08
0.08
2.1
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
74
0.81
0.07
1.0
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
78
1.03
0.07
1.6
1.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
104
0.86
0.06
1.1
2.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
21
197
1.07
0.06
5.2
4.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
47
485
0.96
0.05
1.4
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
16
149
1.08
0.05
1.4
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
74
724
1.03
0.05
2.2
2.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
56
572
0.97
0.03
1.7
1.8
nmol/l
1246.3
1177.3
0.19
47
415
(40761535) Cells panel - Urine sediment
20
191
1.05
0.03
2.4
3.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
18
188
0.95
0.02
6.2
3.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
97
980
0.99
0.02
2.5
2.1
pmol/l
79.9
92.9
3.29
72
500
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
14
147
0.95
0.01
1.1
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
46
466
0.98
0.00
3.3
3.8
ng/l
68.1
219.8
1.61
36
407
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
11
111
0.99
0.00
2.0
4.1
mmol/l
26.1
24.0
1.19
11
105
(3014111) Lactate [Moles/volume] in Serum or Plasma
21
211
0.99
0.00
4.1
6.5
mmol/l
1.0
1.3
0.78
21
198
(3037467) Urinalysis macro (dipstick) panel - Urine
146
1459
1.00
0.00
5.5
4.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
90
895
1.01
0.00
2.8
2.3
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
1.1
—
0
5
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
58
0.86
0.00
1.2
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
0
5
0.00
0.00
0.0
1.4
—
30.2
—
0
5
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
10.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
1246.6
—
0
7
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(44813793)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
5.3
—
0
6
(3033799) Differential panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
7
0.00
0.00
0.0
2.0
—
1.2
—
0
7
(4015189)
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
8
0.00
0.00
0.0
1.6
—
31.3
—
0
8
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
93.6
—
0
7
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
10.0
—
0
6
(3044007) Cell count panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
8
0.00
0.00
0.0
6.8
—
48.7
—
0
8
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
8
0.00
0.00
0.0
2.0
—
1.2
—
0
8
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
57
0.88
0.00
1.2
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
7
0.00
0.00
0.0
1.0
—
4.1
—
0
7
(4034850)
6
69
0.87
0.00
3.7
13.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.6
—
75.8
—
0
8
(3032057) Clostridioides difficile [Presence] in Stool
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
57
0.88
0.00
1.2
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
1.0
—
0
9
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: PDMED_ENTACAPONE – Use of entacapone
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).